Maria B; Orsolya E; Iulian PR; Mihaela T; Aphrodite BA; Anett R; Tamás K; Karen F; Mahmoud O; Renáta P; Péter F; Andrea S; Cristian G; Peter H; Stefania B

Jan 1, 2026Clinical and translational medicine

2026PubMedDirectly related

Postpartum GLP-1 receptor agonists and SGLT-2 therapies in women with prior gestational diabetes: current evidence and uncertainties.

Vanlaer Y; Van de Cauter E; Embo N; Benhalima K

Jan 1, 2026BMC medicine

2026PubMedDirectly related

Acute pancreatitis following semaglutide therapy: a case report.

Alduraibi RK; Fattouta NA; Altowayan YF

Jan 1, 2026Annals of medicine and surgery (2012)

2026PubMedDirectly related

Preoperative GLP-1 receptor agonist use and outcomes after total hip arthroplasty: a matched cohort study.

Diab AR; Chang THW; Diab O; Kheir MM

Jan 1, 2026Hip international : the journal of clinical and experimental research on hip pathology and therapy

2026PubMedDirectly related

Metabolic Effects of a GLP-1 Analog Combined with Aerobic Training in Ovariectomized Rats.

Selau B; Bastos LM; Normann RS; Cubas GK; Herrmann ROCDC; Barros LDAO; de Amaral M; Trapp M; Kucharski LC; Vogt ÉL; Model JFA; Vinagre AS

Jan 1, 2026Molecular and cellular endocrinology

2026PubMedDirectly related

Assessing the Effects of Childhood and Adult Body Mass Index on Diabetic Retinopathy Risk: A Mendelian Randomization Study.

Gao L; Guo S; Zhu W; Zhou Y

Jan 1, 2026Endocrine, metabolic & immune disorders drug targets

2026PubMedDirectly related

Use of incretin receptor agonists in patients submitted to metabolic bariatric surgery - a systematic review and meta-analysis.

Santos-Pereira M; Frutuoso JF; Pereira SS; Guimarães M; Monteiro MP

Jan 1, 2026Frontiers in endocrinology

2026PubMedDirectly related

Where the Future Lies: GLP-1 Receptor Agonists as Therapeutics for Dermatologic Comorbidities.

DeCoster M; Narla S

Jan 1, 2026Clinics in dermatology

2026PubMedDirectly related

Effects of GLP-1 receptor agonists on the incidence of contrast-induced acute kidney injury in patients with Type 2 diabetes mellitus undergoing coronary interventions.

Oksen D; Aslan M; Yavuz YE; Kaynak C; Serin E

Jan 1, 2026Frontiers in endocrinology

2026PubMedDirectly related

Reporting patterns of suicide- and self-injury-related events involving liraglutide, semaglutide, and tirzepatide: data from the European pharmacovigilance database.

Scavone C; Cerasuolo M; Gaio M; Lettera N; Bernardi FF; Capuano A; Rinaldi B

Jan 1, 2026Frontiers in pharmacology

2026PubMedDirectly related

Comparative Efficacy of Promising Targets in the Treatment of Metabolic Dysfunction-associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review and Network Meta-analysis.

Ni W; Li J; Bai X; Zhou S; Wu X; Jia L; Jiang Z; Wu J; Li M; Wong C; Wu C; Shi J; Nguyen MH

Jan 1, 2026Journal of clinical and translational hepatology

2026PubMedDirectly related

Recent advances in the treatment of chronic liver diseases: focus on MASLD/MASH-related fibrosis.

Jędrysik M; Chełstowska B; Tomasiewicz K; Szymański FM

Jan 1, 2026Clinical and experimental hepatology

Page 11 of 21Showing 121-132 of total 251 results.

1...101112...21

GLP-1 receptor agonists for obesity treatment — Research Evidence and Topic... | Kritoma